Condition: Dry Eye · Meibomian Gland Dysfunction (Disorder) · Sponsor: Singapore National Eye Centre
The purpose of this research study is to understand the mechanism of action of low level light therapy and also potentially yield markers associated with good treatment response. Low-level light therapy is light-based treatment delivered through advance eye-light device. This therapy uses light energy to provide energy to the meibomian gland cells to slow down age-ing, improve tear stability and reduce inflammation.
This description comes directly from the study's public registry record.
Louis Tong Tong, PhD · 65767200 · louis.tong.h.t@singhealth.com.sg
Jiayi Lee, MSc · lee.jiayi1@singhealth.com.sg
Always discuss trial participation with your own doctor first.
| Singapore Eye Research Insititute | Singapore, Singapore | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07329712